Eczema drug dupilumab shows promise for better sleep
NCT ID NCT04033367
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested whether dupilumab, an injectable drug that reduces inflammation, can improve sleep quality in adults with moderate-to-severe atopic dermatitis (eczema). 188 participants received either dupilumab or a placebo. The main goal was to measure changes in sleep quality over 12 weeks. The trial is already completed, so results are available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
dupilumab (an injectable biologic drug that blocks inflammation)
What this could lead to
If successful, this could confirm that dupilumab helps people with eczema sleep better, improving their daily life.
What could go wrong
This is a completed Phase 4 trial, so results are already known. It only tested sleep effects, not a cure, and benefits may not apply to everyone with eczema.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Site Number :0360001
Kogarah, New South Wales, 2217, Australia
-
Investigational Site Number :0360003
Carlton, Victoria, 3053, Australia
-
Investigational Site Number :0360006
Phillip, Australian Capital Territory, 2606, Australia
-
Investigational Site Number :0360007
Woolloongabba, Queensland, 4102, Australia
-
Investigational Site Number :2500001
Brest, 29200, France
-
Investigational Site Number :2500002
Paris, 75014, France
-
Investigational Site Number :2500003
Nantes, 44093, France
-
Investigational Site Number :2500006
Toulouse, 31059, France
-
Investigational Site Number :2760001
Göttingen, 37075, Germany
-
Investigational Site Number :2760002
Frankfurt am Main, 60590, Germany
-
Investigational Site Number :2760004
Münster, 48149, Germany
-
Investigational Site Number :2760005
Bad Bentheim, 48455, Germany
-
Investigational Site Number :2760006
Friedrichshafen, 88045, Germany
-
Investigational Site Number :3760003
Jerusalem, 91120, Israel
-
Investigational Site Number :3760005
Afula, 18101, Israel
-
Investigational Site Number :3800001
Pisa, 56126, Italy
-
Investigational Site Number :3800002
Roma, 168, Italy
-
Investigational Site Number :3800003
Siena, 53100, Italy
-
Investigational Site Number :3800004
Reggio Calabria, 86100, Italy
-
Investigational Site Number :3800005
Rozzano, Milano, 20089, Italy
-
Investigational Site Number :3800006
Perugia, 06129, Italy
-
Investigational Site Number :7240001
Barcelona / Sabadell, Castille and León, 08208, Spain
-
Investigational Site Number :7240002
Valencia, 46026, Spain
-
Investigational Site Number :7240003
Manises, Valencia, 46940, Spain
-
Investigational Site Number :7240004
Granada, Andalusia, 18016, Spain
-
Investigational Site Number :7240005
Seville, 41013, Spain
-
Investigational Site Number :7240006
Córdoba, 14004, Spain
-
Investigational Site Number :7240008
Madrid, 28007, Spain
-
Investigational Site Number :7240010
Madrid, 28922, Spain
-
Investigational Site Number :7560001
Bern, 3010, Switzerland
-
Investigational Site Number :7840001
Dubai, United Arab Emirates
-
Investigational Site Number :7840002
Abu Dhabi, 46713, United Arab Emirates
-
Investigational Site Number :8260002
Dudley, Birmingham, DY1 2HQ, United Kingdom
-
Investigational Site Number :8260004
Edinburgh, Edinburgh, City of, EH16 4SA, United Kingdom
-
Investigational Site Number :8400001
Rolling Hills Estates, California, 90274, United States
-
Investigational Site Number :8400002
Redwood City, California, 94063, United States
-
Investigational Site Number :8400003
Sarasota, Florida, 34239, United States
-
Investigational Site Number :8400005
Denver, Colorado, 80230, United States
-
Investigational Site Number :8400007
Medford, Oregon, 97504, United States
-
Investigational Site Number :8400008
Charleston, South Carolina, 29407, United States
-
Investigational Site Number :8400012
North Little Rock, Arkansas, 72117, United States
-
Investigational Site Number :8400013
Colorado Springs, Colorado, 80907, United States